Suicide Prevention for Patients With Chronic Pain
CompletedNot applicableNCT04490265
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients with chronic pain and moderate suicide risk (n=60) will be randomized to receive remote-PST or remote-supportive psychotherapy. We will assess problem-solving deficits through self-report, objective neuropsychological assessment and caregiver report. We have used an adaptive design so that if there is strong evidence for target engagement, we will continue with the trial as a fully powered clinical trial (i.e., the end of the current proposal will act as the interim assessment) to the determine the efficacy of remote PST for patients with chronic pain and moderate suicide risk (n=190) to improve suicide outcomes.
Study details
- Official title
- Suicide Prevention for Patients With Chronic Pain
- Conditions
- Suicide
- Chronic Pain
- Interventions
- Behavioral: Problem-solving treatment
- Behavioral: Supportive Psychotherapy
- Sponsor
- Veterans BioMedical Research Institute
- Collaborators
- Rutgers University
- Start date
- 2020-05-20
- Primary completion
- 2023-12-27
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion criteria will include: * has a VA primary care provider and has had an in-person visit with a VA provider in the past year; * pain that is (b1) musculoskeletal, defined as regional (joints, limbs, back, neck) or more generalized (chronic widespread pain); * pain that is (b2) moderately severe, defined as a Brief Pain Inventory (BPI) intensity item score of 5 or higher for either "average" or "worst" pain in the past week; * pain that is (b3) persistent, (i.e., ≥3 months) * active suicidal ideation defined as scoring a 2 to 4 on the C-SSRS. Exclusion Criteria: * life-threatening condition * severe cognitive impairment * psychotic disorder * pregnant or plans to become pregnant in the next year * suicide attempt in the past year or hospitalization for suicide risk in the past year
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04490265